Cargando…

High incidence of hepatitis B core antibody positivity in metabolic-associated fatty liver disease-related cirrhosis

BACKGROUND AND AIM: The coexistence of metabolic-associated fatty liver disease (MAFLD) in the course of chronic hepatitis B virus infection increases liver-related morbidity. A positive correlation was found between positive hepatitis B core antibody (anti-HBc) and the risk of cirrhosis and hepatoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ergenc, Ilkay, Gokcen, Pinar, Adali, Gupse, Tarik Kani, Haluk, Ozer Demirtas, Coskun, Gunduz, Feyza, Ataizi Celikel, Cigdem, Yilmaz, Yusuf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kare Publishing 2021
Materias:	Research Article - Anti-HBc and MAFLD
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138930/ https://www.ncbi.nlm.nih.gov/pubmed/35782891 http://dx.doi.org/10.14744/hf.2020.2020.0025

Ejemplares similares

Causes of erectile dysfunction in non-alcoholic fatty liver disease
por: Tarik Kani, Haluk, et al.
Publicado: (2021)

The prevalence of metabolic-associated fatty liver disease in the Turkish population: A multicenter study
por: Yilmaz, Yusuf, et al.
Publicado: (2021)

Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease
por: Kaya, Eda, et al.
Publicado: (2022)

Simple Noninvasive Scores Are Clinically Useful to Exclude, Not Predict, Advanced Fibrosis: A Study in Turkish Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease
por: Kaya, Eda, et al.
Publicado: (2020)

Evaluation of the effectiveness of drug-eluting transarterial chemoebolization in hepatocellular carcinoma
por: Alan, Aydan Mutis, et al.
Publicado: (2023)

Insidious danger for young adults: Metabolic (dysfunction)-associated fatty liver disease
por: Kaya, Eda, et al.
Publicado: (2022)

Update on genetics and epigenetics in metabolic associated fatty liver disease
por: Zhu, Xiaopeng, et al.
Publicado: (2022)

MAFLD: what 2 years of the redefinition of fatty liver disease has taught us
por: Grabherr, Felix, et al.
Publicado: (2022)

MAFLD: a multisystem disease
por: Pipitone, Rosaria Maria, et al.
Publicado: (2023)

Non-invasive assessment of metabolic dysfunction–associated fatty liver disease
por: Chandra Kumar, C. Vikneshwaran, et al.
Publicado: (2022)

Emerging pharmacological treatment options for MAFLD
por: Rojas, Ángela, et al.
Publicado: (2022)

Non-pharmacological management options for MAFLD: a practical guide
por: Stefano, José Tadeu, et al.
Publicado: (2023)

Fatty liver disease in children (MAFLD/PeFLD Type 2): unique classification considerations and challenges
por: Hegarty, Robert, et al.
Publicado: (2023)

The bidirectional impacts of alcohol consumption and MAFLD for progressive fatty liver disease
por: Kulkarni, Anand V., et al.
Publicado: (2023)

Should we undertake surveillance for HCC in patients with MAFLD?
por: Norero, Blanca, et al.
Publicado: (2023)

Screening for MAFLD: who, when and how?
por: Pal, Shreya C., et al.
Publicado: (2023)

Prognostic significance of metastatic lymph node ratio in gastric cancer: a Western-center analysis
por: Ergenç, Muhammer, et al.
Publicado: (2023)

Giving anti-VEGF injections: an update from Burundi
por: Niyonzima, Jean Claude
Publicado: (2023)

Metabolic-associated Fatty Liver Disease: Time to integrate ground-breaking new terminology to our clinical practice?
por: Demirtas, Coskun Ozer, et al.
Publicado: (2020)

Effects of vitamin D level on survival in patients with hepatocellular carcinoma
por: Bilgen, Ali, et al.
Publicado: (2020)

Can simple Non-Invasive Fibrosis Models Determine Prognostic Indicators (Fibrosis and Treatment Response) of Primary Biliary Cholangitis?
por: Sayar, Suleyman, et al.
Publicado: (2021)

Are nucleos(t)ide analogues effective against severe outcomes in COVID-19 and hepatitis B virus coinfection?
por: Adali, Gupse, et al.
Publicado: (2021)

A novel approach for rapid screening of mitochondrial D310 polymorphism
por: Aral, Cenk, et al.
Publicado: (2006)

Chronotype preference, sleep quality, and night-eating behaviors in patients with metabolic dysfunction-associated steatotic liver disease: Assessing the relationship with disease severity and fibrosis
por: Kani, Ayse Sakalli, et al.
Publicado: (2023)

Mitochondrial DNA common deletion is not associated with thyroid, breast and colorectal tumors in Turkish patients
por: Aral, Cenk, et al.
Publicado: (2010)

Prolonged Methylprednisolone Therapy in the Fibro-Proliferative Phase of Acute Respiratory Distress Syndrome
por: Kocakaya, Derya, et al.
Publicado: (2021)

The significance of plasma collagen degradation products as biomarkers for advanced hypertensive heart disease
por: Mani, Kevin, et al.
Publicado: (2021)

The paradigm shift in treatment from Covid-19 to oncology with mRNA vaccines
por: Wei, Jiao, et al.
Publicado: (2022)

Angiotensin‐converting enzyme inhibitors increase anti‐fibrotic biomarkers in African Americans with left ventricular hypertrophy
por: A. Romero, Cesar, et al.
Publicado: (2021)

Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials
por: Sobhani, Navid, et al.
Publicado: (2022)

The risk of development of primary biliary cholangitis among incidental antimitochondrial M2 antibody-positive patients
por: Ergenc, Ilkay, et al.
Publicado: (2023)

Directed Search of Anti-inflammatory Agents Among (3H-Quinazoline-4-ylidene)hydrazides of N-protected Amino acids and their Heterocyclization Products
por: Martynenko, Yulya, et al.
Publicado: (2020)

The Impact of Inflammatory Profile on Selenium Levels in Hemodialysis Patients
por: Bacci, Marcelo R., et al.
Publicado: (2020)

Anti-inflammatory Property of AMP-activated Protein Kinase
por: Noor, Humaira B., et al.
Publicado: (2020)

Change in standardized uptake values in delayed (18)F-FDG positron emission tomography images in hepatocellular carcinoma
por: Oksuzoglu, Kevser, et al.
Publicado: (2018)

Validation of the PAGE-B score to predict hepatocellular carcinoma risk in caucasian chronic hepatitis B patients on treatment
por: Gokcen, Pinar, et al.
Publicado: (2022)

Atypical Presentation of Cat-Scratch Disease in an Immunocompetent Child with Serological and Pathological Evidence
por: Atıcı, Serkan, et al.
Publicado: (2014)

Immunosuppressive drugs : developments in anti-rejection therapy
Publicado: (1994)

Multiple recurrences of anti-glomerular basement membrane disease with variable antibody detection: can the laboratory be trusted?
por: Liu, Patricia, et al.
Publicado: (2016)

Frequently relapsing anti-glomerular basement membrane antibody disease with changing clinical phenotype and antibody characteristics over time
por: Gu, Bobby, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qur1l4ng74mnhi7felog9jnn4i